Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492359 · ClinicalTrials.gov registry record · NA
Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)
A NA study, sponsored by Landon Pediatric Foundation.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03492359: Completed NA study, sponsored by Landon Pediatric Foundation.
NCT03492359 is a NA study that has completed, run by Landon Pediatric Foundation. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03492359, a NA study, has completed, sponsored by Landon Pediatric Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
To demonstrate differences in tidal breathing patterns measured by SLP(Structured Light Plethysmography) between healthy subjects and COPD (chronic obstructive pulmonary disease). The correlation between SLP parameters and standard lung function parameters measured by body box and spirometry will also be assessed. Trends in SLP breathing patterns between the different GOLD (Global Initiative for Chronic Obstructive Lung Disease) stages of COPD, and between those and healthy subjects, will be investigated to assess whether SLP can detect differences between groups.
Primary Outcome
SLP breathing parameters derived from the movement of the thoracoabdominal (TA) wall during tidal breathing
Interventions
- DEVICE Thora-3Di
- DEVICE Body Plethysmography
- DEVICE Spirometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2019-01-01 |
| Phase | NA |
What the finished NCT03492359 record still lists
NCT03492359 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Thora-3Di is the first listed.
NCT03492359 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03492359 about?
NCT03492359 is a clinical study titled "Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)". To demonstrate differences in tidal breathing patterns measured by SLP(Structured Light Plethysmography) between healthy subjects and COPD (chronic obstructive pulmonary disease). The correlation between SLP parameters and standard lung function parameters measured by body box and spirometry will al...
What is the current status of trial NCT03492359?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2017-05-01. Estimated completion is 2019-01-01.
What interventions are being tested in trial NCT03492359?
The interventions under investigation include: Thora-3Di (DEVICE), Body Plethysmography (DEVICE), Spirometry (DEVICE).
Who is sponsoring clinical trial NCT03492359?
This trial is sponsored by Landon Pediatric Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03492359's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI